Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: India

Reliance Pharma Fund

+ Add to Watchlist

RELPHRB:IN

127.29 INR 0.84 0.66%

As of 00:59:30 ET on 02/27/2015.

Snapshot for Reliance Pharma Fund (RELPHRB)

Year To Date: +1.34% 3-Month: +1.61% 3-Year: +33.39% 52-Week Range: 84.00 - 131.02
1-Month: -1.86% 1-Year: +44.58% 5-Year: +24.04% Beta vs BSETHC: 0.86

Mutual Fund Chart for RELPHRB

No chart data available.
  • RELPHRB:IN 127.29
  • 1M
  • 1Y
Interactive RELPHRB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RELPHRB

Reliance Pharma Fund is an open-ended fund incorporated in India. The Fund seeks to generate consistent returns by investing in equity and equity related instruments or fixed income securities of the companies that cater to any segment of the pharmaceutical chain. The Fund invests in the debt and money market instruments with an average maturity of five to ten years.

Inception Date: 05-26-2004 Telephone: 91-22-3099-4600 Tel
Managers: SAILESH RAJ BHAN
Web Site: www.reliancemutual.com

Fundamentals for RELPHRB

NAV (on 2015-02-27) 127.29
Assets (M) (on 2015-01-30) 12,109.29
Fund Leveraged N
Minimum Investment 10,000.00
Minimum Subsequent Investment -

Dividends for RELPHRB

No dividends reported

Fees & Expenses for RELPHRB

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 1.07
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 2.46

Top Fund Holdings for RELPHRB

Filing Date: 01/30/2015
Name Position Value % of Total
Abbott India Ltd 399,706 1,589,410,924 13.126%
Cadila Healthcare Ltd 829,599 1,359,173,522 11.224%
Sun Pharmaceutical Industries 1,350,000 1,238,962,500 10.232%
Divi's Laboratories Ltd 640,000 1,115,104,000 9.209%
Lupin Ltd 690,000 1,093,857,000 9.033%
Cipla Ltd/India 1,250,303 869,898,312 7.184%
Dr Reddy's Laboratories Ltd 265,871 859,627,411 7.099%
Sanofi India Ltd 248,231 822,426,538 6.792%
Ipca Laboratories Ltd 1,227,400 783,449,420 6.470%
FDC Ltd/India 3,004,958 495,968,318 4.096%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil